Devoted Health valuation, funding and investors
Devoted Health works in medicare advantage plan design and management, based in Eagan, United States. Founded in 2017, it has about 2,370 employees.
- Last round
- Series F · $48.0M · Nov 2025
- Valuation at last round
- $13.27B
- Headcount
- 2,371 · up
- Grade
- A
- Founded
- 2017
Devoted Health valuation today
VCMC values Devoted Health at $18.0B today, with a range of $11.5B to $20.8B and a grade of A. The valuation starts from its last funding round, a Series F round in Nov 2025.
Valuation by date (126 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2017 | $8.37M | $3.05M – $23.0M | $11.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $8.60M | $3.13M – $23.6M | $11.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $8.81M | $3.21M – $24.2M | $12.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $9.05M | $3.29M – $24.9M | $12.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $9.29M | $3.38M – $25.5M | $12.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $9.54M | $3.47M – $26.2M | $13.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $9.79M | $3.56M – $26.9M | $13.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $10.1M | $3.66M – $27.6M | $13.8M (+37%) | before first round | – | unknown | D | 0% |
| 23 Aug 2017 | $28.1M | $18.4M – $85.2M | $56.0M (+100%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $28.5M | $18.4M – $85.2M | $56.0M (+96%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $30.2M | $18.4M – $85.2M | $56.0M (+85%) | after a round | – | unknown | C | 0% |
| 7 Oct 2017 | $144M | $102M – $368M | $259M (+80%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $150M | $102M – $368M | $259M (+73%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $158M | $102M – $368M | $259M (+64%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $166M | $102M – $368M | $259M (+56%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $174M | $102M – $368M | $259M (+49%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $182M | $102M – $368M | $259M (+42%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $192M | $102M – $368M | $259M (+35%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $201M | $102M – $368M | $259M (+29%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $211M | $102M – $368M | $259M (+23%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $222M | $102M – $368M | $259M (+17%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $233M | $102M – $368M | $259M (+11%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $245M | $102M – $368M | $259M (+6%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $257M | $102M – $368M | $259M (+1%) | after a round | – | unknown | C | 0% |
| 17 Oct 2018 | $1.1B | $754M – $2.3B | $1.6B (+50%) | after a round | – | unknown | B | 0% |
| 1 Nov 2018 | $1.1B | $754M – $2.3B | $1.6B (+47%) | after a round | – | unknown | B | 0% |
| 1 Dec 2018 | $1.1B | $754M – $2.3B | $1.6B (+43%) | after a round | – | unknown | B | 0% |
| 1 Jan 2019 | $1.2B | $754M – $2.3B | $1.6B (+38%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $1.2B | $754M – $2.3B | $1.6B (+33%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $1.2B | $754M – $2.3B | $1.6B (+29%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $1.3B | $754M – $2.3B | $1.6B (+25%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $1.3B | $754M – $2.3B | $1.6B (+21%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $1.4B | $754M – $2.3B | $1.6B (+16%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $1.4B | $754M – $2.3B | $1.6B (+13%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $1.5B | $754M – $2.3B | $1.6B (+9%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $1.5B | $754M – $2.3B | $1.6B (+5%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $1.6B | $754M – $2.3B | $1.6B (+2%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $1.6B | $737M – $2.3B | $1.6B (0%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $1.6B | $707M – $2.3B | $1.6B (0%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $1.6B | $676M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $1.6B | $647M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $1.6B | $621M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $1.6B | $594M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $1.6B | $569M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $1.6B | $544M – $2.3B | $1.6B (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $2.9B | $2.1B – $5.4B | $3.8B (+30%) | after a round | – | unknown | B | 0% |
| 2 Jul 2020 | $2.9B | $2.1B – $5.4B | $3.8B (+30%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $3.0B | $2.1B – $5.4B | $3.8B (+27%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $3.1B | $2.1B – $5.4B | $3.8B (+24%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $3.1B | $2.1B – $5.4B | $3.8B (+22%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $3.2B | $2.1B – $5.4B | $3.8B (+19%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $3.3B | $2.1B – $5.4B | $3.8B (+16%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $3.3B | $2.1B – $5.4B | $3.8B (+14%) | after a round | 420 | unknown | B | 0% |
| 1 Feb 2021 | $3.4B | $2.1B – $5.4B | $3.8B (+11%) | after a round | 420 | unknown | B | 0% |
| 1 Mar 2021 | $3.5B | $2.1B – $5.4B | $3.8B (+9%) | after a round | 420 | unknown | B | 0% |
| 1 Apr 2021 | $3.6B | $2.1B – $5.4B | $3.8B (+7%) | after a round | 420 | flat | B | 0% |
| 1 May 2021 | $3.6B | $2.1B – $5.4B | $3.8B (+4%) | after a round | 420 | flat | B | 0% |
| 1 Jun 2021 | $3.7B | $2.1B – $5.4B | $3.8B (+2%) | after a round | 420 | flat | B | 0% |
| 1 Jul 2021 | $3.8B | $2.1B – $5.4B | $3.8B (0%) | after a round | 420 | flat | B | 0% |
| 1 Aug 2021 | $3.8B | $2.0B – $5.4B | $3.8B (0%) | after a round | 420 | flat | B | 0% |
| 1 Sep 2021 | $3.8B | $1.9B – $5.4B | $3.8B (0%) | after a round | 420 | flat | B | 0% |
| 1 Oct 2021 | $3.8B | $1.8B – $5.4B | $3.8B (0%) | after a round | 420 | flat | B | 0% |
| 9 Oct 2021 | $12.7B | $11.0B – $19.0B | $16.5B (+30%) | after a round | 420 | flat | A | 0% |
| 1 Nov 2021 | $12.9B | $11.0B – $19.0B | $16.5B (+28%) | after a round | 420 | flat | A | 0% |
| 1 Dec 2021 | $13.2B | $11.0B – $19.0B | $16.5B (+25%) | after a round | 420 | flat | A | 0% |
| 1 Jan 2022 | $13.5B | $11.0B – $19.0B | $16.5B (+22%) | after a round | 420 | flat | A | 0% |
| 1 Feb 2022 | $13.8B | $11.0B – $19.0B | $16.5B (+20%) | after a round | 420 | flat | A | 0% |
| 1 Mar 2022 | $14.1B | $11.0B – $19.0B | $16.5B (+17%) | after a round | 850 | growing | A | 0% |
| 1 Apr 2022 | $14.4B | $11.0B – $19.0B | $16.5B (+15%) | after a round | 850 | growing | A | 0% |
| 1 May 2022 | $14.7B | $11.0B – $19.0B | $16.5B (+12%) | after a round | 850 | growing | A | 0% |
| 1 Jun 2022 | $15.0B | $11.0B – $19.0B | $16.5B (+10%) | after a round | 850 | growing | A | 0% |
| 1 Jul 2022 | $15.4B | $11.0B – $19.0B | $16.5B (+7%) | after a round | 850 | growing | A | 0% |
| 1 Aug 2022 | $15.7B | $11.0B – $19.0B | $16.5B (+5%) | after a round | 850 | growing | A | 0% |
| 1 Sep 2022 | $16.1B | $11.0B – $19.0B | $16.5B (+3%) | after a round | 850 | growing | A | 0% |
| 1 Oct 2022 | $16.4B | $11.0B – $19.0B | $16.5B (+1%) | after a round | 850 | growing | A | 0% |
| 1 Nov 2022 | $16.5B | $10.7B – $19.0B | $16.5B (0%) | after a round | 850 | unknown | A | 0% |
| 1 Dec 2022 | $16.5B | $10.2B – $19.0B | $16.5B (0%) | after a round | 850 | unknown | B | 0% |
| 1 Jan 2023 | $17.8B | $11.4B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Feb 2023 | $17.8B | $11.5B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Mar 2023 | $17.8B | $11.7B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Apr 2023 | $17.8B | $11.8B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 May 2023 | $17.8B | $12.0B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Jun 2023 | $17.8B | $12.1B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Jul 2023 | $17.8B | $12.2B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Aug 2023 | $17.8B | $12.4B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Sep 2023 | $17.8B | $12.5B – $20.5B | $17.8B (0%) | after a round | 1,200 | growing | A | 0% |
| 1 Oct 2023 | $18.4B | $10.8B – $21.2B | $18.4B (0%) | after a round | 1,400 | up | B | 0% |
| 1 Nov 2023 | $18.4B | $9.7B – $21.2B | $18.4B (0%) | after a round | 1,400 | up | B | 0% |
| 1 Dec 2023 | $18.4B | $9.5B – $21.2B | $18.3B (-1%) | after a round | 1,400 | up | B | 0% |
| 30 Dec 2023 | $12.9B | $11.2B – $19.2B | $16.7B (+30%) | after a round | 1,400 | up | A | 0% |
| 1 Jan 2024 | $12.9B | $11.2B – $19.2B | $16.7B (+30%) | after a round | 1,400 | up | A | 0% |
| 1 Feb 2024 | $13.2B | $11.2B – $19.2B | $16.7B (+27%) | after a round | 1,400 | up | A | 0% |
| 1 Mar 2024 | $13.5B | $11.2B – $19.2B | $16.7B (+24%) | after a round | 1,500 | up | A | 0% |
| 1 Apr 2024 | $13.8B | $11.2B – $19.2B | $16.7B (+22%) | after a round | 1,500 | up | A | 0% |
| 1 May 2024 | $14.1B | $11.2B – $19.2B | $16.7B (+19%) | after a round | 1,500 | up | A | 0% |
| 1 Jun 2024 | $14.4B | $11.2B – $19.2B | $16.7B (+16%) | after a round | 1,500 | up | A | 0% |
| 1 Jul 2024 | $14.7B | $11.2B – $19.2B | $16.7B (+14%) | after a round | 1,500 | up | A | 0% |
| 1 Aug 2024 | $15.2B | $11.2B – $19.5B | $17.0B (+12%) | after a round | 1,600 | up | A | 0% |
| 1 Sep 2024 | $15.5B | $11.2B – $19.5B | $17.0B (+9%) | after a round | 1,600 | up | A | 0% |
| 1 Oct 2024 | $15.9B | $11.2B – $19.5B | $17.0B (+7%) | after a round | 1,600 | up | A | 0% |
| 1 Nov 2024 | $16.4B | $11.2B – $19.8B | $17.2B (+5%) | after a round | 1,700 | up | A | 0% |
| 1 Dec 2024 | $16.8B | $11.2B – $19.8B | $17.2B (+2%) | after a round | 1,700 | up | A | 0% |
| 1 Jan 2025 | $17.2B | $11.2B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | A | 0% |
| 1 Feb 2025 | $17.2B | $11.1B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | A | 0% |
| 1 Mar 2025 | $17.2B | $11.0B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | A | 0% |
| 1 Apr 2025 | $17.2B | $10.9B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | A | 0% |
| 1 May 2025 | $17.2B | $10.8B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | B | 0% |
| 1 Jun 2025 | $17.2B | $10.7B – $19.8B | $17.2B (0%) | after a round | 1,700 | up | B | 0% |
| 1 Jul 2025 | $17.5B | $10.7B – $20.2B | $17.5B (0%) | after a round | 1,860 | up | B | 0% |
| 1 Aug 2025 | $17.6B | $10.7B – $20.2B | $17.6B (0%) | after a round | 1,878 | up | B | 0% |
| 1 Sep 2025 | $17.6B | $10.6B – $20.2B | $17.6B (0%) | after a round | 1,878 | up | B | 0% |
| 1 Oct 2025 | $17.6B | $10.5B – $20.3B | $17.6B (0%) | after a round | 1,909 | up | B | 0% |
| 1 Nov 2025 | $13.3B | $11.5B – $19.8B | $17.3B (+30%) | after a round | 1,909 | up | A | 0% |
| 2 Nov 2025 | $13.3B | $11.5B – $19.8B | $17.3B (+30%) | after a round | 1,909 | up | A | 0% |
| 1 Dec 2025 | $13.6B | $11.5B – $19.8B | $17.3B (+27%) | after a round | 1,909 | up | A | 0% |
| 1 Jan 2026 | $13.9B | $11.5B – $20.1B | $17.4B (+26%) | after a round | 2,005 | up | A | 0% |
| 1 Feb 2026 | $14.2B | $11.5B – $20.1B | $17.4B (+23%) | after a round | 2,005 | up | A | 0% |
| 1 Mar 2026 | $14.5B | $11.5B – $20.1B | $17.4B (+20%) | after a round | 2,005 | up | A | 0% |
| 1 Apr 2026 | $14.9B | $11.5B – $20.1B | $17.4B (+17%) | after a round | 2,005 | up | A | 0% |
| 1 May 2026 | $15.3B | $11.5B – $20.4B | $17.7B (+16%) | after a round | 2,164 | up | A | 0% |
| 1 Jun 2026 | $15.7B | $11.5B – $20.4B | $17.7B (+13%) | after a round | 2,164 | up | A | 0% |
| 1 Jul 2026 | $16.1B | $11.5B – $20.4B | $17.7B (+10%) | after a round | 2,164 | up | A | 0% |
| 1 Aug 2026 | $16.5B | $11.5B – $20.5B | $17.8B (+8%) | after a round | 2,214 | up | A | 0% |
| 1 Sep 2026 | $17.0B | $11.5B – $20.5B | $17.8B (+5%) | after a round | 2,214 | up | A | 0% |
| 1 Oct 2026 | $17.6B | $11.5B – $20.8B | $18.1B (+3%) | after a round | 2,371 | up | A | 0% |
| 24 Oct 2026 | $18.0B | $11.5B – $20.8B | $18.1B (+1%) | after a round | 2,371 | up | A | 0% |
Key facts about Devoted Health
- Founded
- 2017
- Headquarters
- Eagan, United States
- Employees
- about 2,370 +24% in a year
- Total raised
- $2.17B
- Funding rounds
- 7
- Last round
- Series F Nov 2025
Devoted Health was founded in 2017 by Ed Park and Todd Park.
Devoted Health funding history
Devoted Health has 7 funding rounds on record, from Aug 2017 to Nov 2025, $2.17B in total. The latest disclosed valuation is $13.27B post-money (Series F, Nov 2025).
Series F 1 Nov 2025
Led by Centricus; with GV, VanEck, MIG Private Equity, Premji Invest, The Private Shares Fund, NextView Ventures, Emerson Collective, Andreessen Horowitz, Stardust Equity, General Catalyst, Frist Cressey Ventures, Fearless Ventures.
Sources: devoted.com
$48M
$13.27B post-money
Series E 29 Dec 2023
Led by The Space Between (TSB), Highbury Group, GIC, Stardust, Maverick Ventures, Fearless Ventures; with Socium Ventures, Emerson Collective, Andreessen Horowitz, The Private Shares Fund, F-Prime Capital, General Catalyst, GreatPoint Ventures, SoftBank Vision Fund, Uprising Capital, Frist Cressey Ventures, NextView Ventures, Base10 Partners, Premji Invest, Iconiq Capital, Rogue Insight Capital, Obvious.
Sources: insurtechinsights.com, devoted.com
$175M
$12.87B post-money
Series D 8 Oct 2021
With Andreessen Horowitz, Base10 Partners, Emerson Collective, Frist Cressey Ventures, General Catalyst, GIC, Iconiq Capital, Maverick Ventures, NextView Ventures, Premji Invest, Uprising, Venrock, GreatPoint Ventures, Rogue Insight Capital.
Sources: statnews.com
$1.20B
$12.70B post-money
Series C 1 Jul 2020
Led by Uprising; with Motley Fool Ventures, Green Sands Equity, Hamish Baillieu, ARTFO Holdings, For Good Ventures.
Sources: insurtechinsights.com
$380M
Series B 16 Oct 2018
Led by Andreessen Horowitz; with Premji Invest, Uprising, Venrock, Maverick Ventures, StartUp Health, Obvious, Oak HC/FT, F-Prime Capital, Flat World Partners, Blue Cross and Blue Shield Association, Dreamers VC.
Sources: techcrunch.com, fcventures.com, medcitynews.com and 1 more
$300M
Series A 6 Oct 2017
Led by Andreessen Horowitz; with Obvious, F-Prime Capital, Maverick Ventures, Cox Enterprises, White Road Investments, General Catalyst.
$62M
Seed 22 Aug 2017
Led by Venrock.
$7.0M
Devoted Health investors
41 investors have backed Devoted Health; Andreessen Horowitz, Maverick Ventures and Uprising and 7 more led at least one round.
- Andreessen Horowitz lead, 5 rounds
- Maverick Ventures lead, 4 rounds
- Uprising lead, 3 rounds
- Venrock lead, 3 rounds
- GIC lead, 2 rounds
- The Space Between (TSB) lead
- General Catalyst 4 rounds
- Premji Invest 4 rounds
- Emerson Collective 3 rounds
- Iconiq Capital 2 rounds
- Blue Cross and Blue Shield Association
- Cox Enterprises
- Flat World Partners
- GV
- Hamish Baillieu
- MIG Private Equity
- Oak HC/FT
- SoftBank Vision Fund
- Stardust Equity
- Uprising Capital
What Devoted Health does
Devoted Health works in insurance - agents, carriers & brokers, with 14 recorded offerings and customers in healthcare.
Devoted Health, Inc. is a United States healthcare company engaged in Medicare Advantage plans and related services, with a focus on supporting older Americans. The company provides Medicare Advantage plans that include health and wellness benefits such as food and home allowances, dental coverage, prescription drugs, and routine hearing exams. Devoted Health also operates a technology platform for member engagement and offers in-house clinicians through Devoted Medical, which provides virtual and in-home care, telemedical services, and clinical programming. The company serves members across 29 states in the United States.
Description from Veridion's company data.
Products and services
- Medicare Advantage Plan Design and Management
- Health and Wellness Benefit Integration
- Dental Coverage Integration
- Prescription Drug Benefit Integration
- Hearing Exam Benefit Integration
- Food and Home Allowance Distribution
- Virtual Care Services
- In-Home Care Services
- Telemedical Services
- Clinical Programming Services
- Member Engagement Technology Platform Development
- Coordinated Patient-Centered Care Delivery
- Provider Access Services
- Member Well-Being Support Services
Markets
- Healthcare
Technology
- Telemedical Services
- Virtual Care
- In-Home Care
Certifications
- HIPAA compliant
Business model
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 524114 Direct Health and Medical Insurance Carriers 50% match
- 621610 Home Health Care Services 30% match
- 541512 Computer Systems Design Services 20% match
Questions about Devoted Health
What is Devoted Health worth?
Valuation $18.0B (range $11.5B to $20.8B), as of 24 Oct 2026. The last disclosed valuation was $13.27B (Series F, Nov 2025).
Has Devoted Health raised money?
Devoted Health has 7 funding rounds on record, from Aug 2017 to Nov 2025, $2.17B in total. The latest disclosed valuation is $13.27B post-money (Series F, Nov 2025).
Who has invested in Devoted Health?
Andreessen Horowitz, Maverick Ventures, Uprising, Venrock, Fearless Ventures and GIC, and 35 more. Lead investors include Andreessen Horowitz, Maverick Ventures, Uprising and Venrock.
How many people work at Devoted Health?
About 2,370, up 24% over the last year. Headcount grew from 420 in Jan 2021 to 2,371 in Sep 2026.
What does Devoted Health do?
Devoted Health works in insurance - agents, carriers & brokers, with 14 recorded offerings and customers in healthcare. Its main offerings are medicare advantage plan design and management, health and wellness benefit integration and dental coverage integration.
When was Devoted Health founded, and where is it based?
Devoted Health was founded in 2017 and is based in Eagan, United States. It has about 2,370 employees, up 24% over the last year.